|
RSU1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.723300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.315900E-02 |
| Normal-vs-Stage2 |
7.222200E-02 |
| Normal-vs-Stage3 |
2.976800E-03 |
| Normal-vs-Stage4 |
2.073900E-02 |
| Stage1-vs-Stage2 |
4.236000E-01 |
| Stage1-vs-Stage3 |
6.609500E-02 |
| Stage1-vs-Stage4 |
2.480000E-01 |
| Stage2-vs-Stage3 |
6.691600E-01 |
| Stage2-vs-Stage4 |
8.204000E-01 |
| Stage3-vs-Stage4 |
8.426600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.435400E-03 |
| Normal-vs-AfricanAmerican |
1.639030E-01 |
| Normal-vs-Asian |
3.460800E-01 |
| Caucasian-vs-AfricanAmerican |
7.449200E-01 |
| Caucasian-vs-Asian |
3.373000E-01 |
| AfricanAmerican-vs-Asian |
7.295200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.223500E-02 |
| Normal-vs-Female |
6.543500E-03 |
| Male-vs-Female |
6.076600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.684400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.190600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.013950E-02 |
| Normal-vs-Age(81-100Yrs) |
7.869400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.775300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.675800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.023600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.759800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.012800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.948200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.988000E-01 |
| Classical-VS-Follicular |
3.889600E-01 |
| Classical-VS-Other |
6.873200E-01 |
| Classical-VS-Normal |
3.685600E-02 |
| Tall-VS-Follicular |
5.525400E-01 |
| Tall-VS-Other |
7.691000E-01 |
| Tall-VS-Normal |
2.328200E-01 |
| Follicular-VS-Other |
5.315000E-01 |
| Follicular-VS-Normal |
2.121800E-02 |
| Other-VS-Normal |
8.149600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.807100E-04 |
| Normal-vs-N1 |
1.134400E-01 |
| N0-vs-N1 |
3.272800E-01 |
|
|
